Landau B. Jeffrey's most recent trade in CytomX Therapeutics Inc was a trade of 11,250 Performance Stock Units (PSUs) done . Disclosure was reported to the exchange on Aug. 20, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| CytomX Therapeutics Inc | Jeffrey B. Landau | Chief Business Officer | 20 Aug 2024 | 11,250 | 0 | - | - | Performance Stock Units (PSUs) | ||
| CytomX Therapeutics Inc | Jeffrey B. Landau | Chief Business Officer | 20 Aug 2024 | 11,250 | 123,237 (0%) | 0% | 0 | Common Stock | ||
| CytomX Therapeutics Inc | Jeffrey B. Landau | Chief Business Officer | 20 Aug 2024 | 4,181 | 119,056 (0%) | 0% | 1.2 | 5,139 | Common Stock | |
| CytomX Therapeutics Inc | Jeffrey B. Landau | Chief Business Officer | 19 Mar 2024 | 6,562 | 110,060 (0%) | 0% | 2.1 | 13,685 | Common Stock | |
| CytomX Therapeutics Inc | Landau B. Jeffrey | Chief Business Officer | 18 Jan 2024 | 140,000 | 140,000 | - | - | Stock Option (Right to Buy) | ||
| CytomX Therapeutics Inc | Jeffrey B. Landau | Chief Business Officer | 18 Jan 2024 | 75,000 | 75,000 | - | - | Performance Stock Units (PSUs) | ||
| CytomX Therapeutics Inc | B. Jeffrey Landau | Chief Business Officer | 18 Jan 2024 | 30,000 | 116,622 (0%) | 0% | 0 | Common Stock | ||
| CytomX Therapeutics Inc | B. Jeffrey Landau | Chief Business Officer | 20 Dec 2023 | 4,077 | 86,622 (0%) | 0% | 1.4 | 5,628 | Common Stock | |
| CytomX Therapeutics Inc | Jeffrey B. Landau | Chief Business Officer | 17 Dec 2023 | 11,250 | 11,250 | - | - | Performance Stock Units (PSUs) | ||
| CytomX Therapeutics Inc | B. Jeffrey Landau | Chief Business Officer | 17 Dec 2023 | 11,250 | 90,699 (0%) | 0% | 0 | Common Stock | ||
| CytomX Therapeutics Inc | Landau Jeffrey B. | Chief Business Officer | 20 Sep 2023 | 11,250 | 80,498 (0%) | 0% | 0 | Common Stock | ||
| CytomX Therapeutics Inc | B. Jeffrey Landau | Chief Business Officer | 20 Sep 2023 | 4,119 | 76,379 (0%) | 0% | 1.3 | 5,356 | Common Stock | |
| CytomX Therapeutics Inc | Jeffrey B. Landau | Chief Financial Officer | 16 Mar 2023 | 1,477 | 69,248 (0%) | 0% | 2.0 | 2,923 | Common Stock | |
| CytomX Therapeutics Inc | Jeffrey B. Landau | Chief Business Officer | 02 Feb 2023 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | ||
| CytomX Therapeutics Inc | Jeffrey B. Landau | Chief Business Officer | 02 Feb 2023 | 75,000 | 75,000 | - | - | Performance Stock Units (PSUs) | ||
| CytomX Therapeutics Inc | Jeffrey B. Landau | Chief Business Officer | 02 Feb 2023 | 40,000 | 70,725 (0%) | 0% | 0 | Common Stock | ||
| CytomX Therapeutics Inc | Jeffrey B. Landau | Chief Business Officer | 19 Jul 2022 | 11,250 | 34,931 (0%) | 0% | 0 | Common Stock | ||
| CytomX Therapeutics Inc | Jeffrey B. Landau | Chief Business Officer | 19 Jul 2022 | 4,206 | 30,725 (0%) | 0% | 1.4 | 5,982 | Common Stock |